Filing Details
- Accession Number:
- 0001562180-24-002591
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-12 16:19:27
- Reporting Period:
- 2024-03-11
- Accepted Time:
- 2024-03-12 16:19:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1822462 | Foghorn Therapeutics Inc. | FHTX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1913484 | Fanny Cavalie | 500 Technology Square Ste #700 Cambridge MA 02139 | Chief Strategy/Bus Ops Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-03-11 | 11,000 | $6.56 | 75,992 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $6.50 USD to $6.83 USD; the price reported above reflects the weighted average sale price.